Solaiman Shereen 4
Research Summary
AI-generated summary
Myriad Genetics (MYGN) CPO Solaiman Shereen Sells 1,675 Shares
What Happened Solaiman Shereen, Chief People Officer of Myriad Genetics (MYGN), had 1,675 shares of common stock withheld on March 1, 2026 to satisfy tax withholding obligations tied to the vesting of previously granted restricted stock units (RSUs). The withholding was reported as a disposition at an effective withholding price of $4.61 per share, for a total value of $7,722.
Key Details
- Transaction date: 2026-03-01; filing date: 2026-03-02 (Form 4) — appears timely (within the usual 2-business-day window).
- Transaction type/code: F — shares withheld to satisfy tax liabilities from RSU vesting.
- Price and value: 1,675 shares × $4.61 = $7,722.
- Footnote: The number of shares withheld was determined using the issuer’s closing price on February 27, 2026.
- Shares owned after transaction: Not specified in the provided filing.
Context This was a routine tax-withholding transaction associated with RSU vesting, not an open-market sale or purchase. Such withholdings are common and generally do not signal bullish or bearish insider intent.